QSOX1-L Based Cancer Test
Early Cancer Detection
PrototypePatent Filed
Key Facts
About Axim Biotech
AXIM Biotechnologies is a diagnostic-focused R&D company with a mission to improve patient lives through rapid, in-clinic testing solutions. The company has achieved commercial validation with two FDA-cleared ophthalmological diagnostics and is leveraging its integrated platform to diversify into early cancer detection and cannabinoid research. Its strategy combines direct commercialization, strategic alliances, and a client-focused diagnostic development service to address unmet needs in multiple therapeutic areas.
View full company profileTherapeutic Areas
Other Early Cancer Detection Drugs
| Drug | Company | Phase |
|---|---|---|
| Pearsanta | Aditx Therapeutics | Platform / Asset |
| Genome Structure Analysis Reagents | Avidin | Development |